• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Select Health, Mark Cuban Cost Plus Drug Company Partner on Lowering Prescription Drug Costs


Collaboration aims to cut medication costs for patients with conditions ranging from high blood pressure to diabetes.

Image Credit: Adobe Stock Images/lexp880

Image Credit: Adobe Stock Images/lexp880

Select Healthand and its pharmacy benefits manager (PBM), Scripius, are providing member access to Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). This collaboration gives Select Health members direct access to Cuban’s prescription drug service.

According to the parties, Select Health, Scripius, and Cost Plus Drugs share the goal of helping consumers understand the cost of their prescriptions and secure the best pricing. Each aim to provide a transparent process to ensure people can access the prescriptions they need to stay healthy. The partnership includes medications for many common conditions, including high blood pressure, certain cancers, dementia, asthma, diabetes, and more.

“As a practicing physician, I saw first-hand the danger of patients not taking their medications because they couldn't afford them,” comments Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. “We are excited to now be working with Select Health and PBMs like Scripius to further reduce the cost to patients, and to keep the patient record complete from both a clinical and financial perspective.”

Related Videos
Related Content